GlassScriptPhysician profile
Zekun Feng
NPI 1184965873
$37,728.83
in general payments reported to CMS, 2019-2025
18 companies · $19K in 2025
The $19K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $532 · 2022: $1,090 · 2023: $3,124 · 2024: $14K · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $28K · Food and Beverage: $4,362 · Travel and Lodging: $3,293 · Education: $920 · Entertainment: $32.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $27,500.00 |
| Food and Beverage | $4,362.06 |
| Travel and Lodging | $3,293.01 |
| Education | $919.50 |
| Entertainment | $32.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $16,923.24 | 2022-2025 | Ensite Precision, Tacticath, Assurity |
| Medtronic, INC. | $9,511.49 | 2023-2025 | Selectsecure, Linq II, Micra |
| Boston Scientific Corporation | $8,750.00 | 2024-2025 | Emblem Mri S-Icd |
| Biotronik INC. | $568.42 | 2024-2025 | Biomonitor, Amvia Edge |
| Biosense Webster, INC. | $459.20 | 2025 | Carto 3 |
| Janssen Pharmaceuticals, INC | $338.98 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $333.39 | 2021-2023 | Lifevest |
| Actelion Pharmaceuticals US, INC. | $194.07 | 2021-2022 | |
| Kestra Medical Technology Services, INC. | $123.16 | 2025 | Assure Wcd |
| Boehringer Ingelheim Pharmaceuticals, INC. | $92.89 | 2021 | |
| Amgen INC. | $78.21 | 2022 | |
| Chiesi USA, INC. | $75.72 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $68.83 | 2021 | |
| Pfizer INC. | $62.26 | 2021 | |
| Astellas Pharma US INC | $45.95 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $45.42 | 2022 | |
| Stereotaxis INC | $32.72 | 2024-2025 | Genesis |
| Cardiva Medical, INC. | $24.88 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zekun Feng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.